Single-Cell Genome Sequencing Market was valued US$ 1.79 Bn in 2022 and is expected to reach US$ 4.57 Bn by 2029, at a CAGR of 14.32 % during a forecast period. The report has analyzed revenue impact of the COVID-19 pandemic on the sales revenue of the market leader, market followers and market disrupters in the report and same is reflected in our analysis.To know about the Research Methodology :- Request Free Sample Report The Single-cell sequencing has emerged as an innovative method, which reveals biological process with unprecedented resolution and scale. It is also an effective approach to characterize organisms, which are difficult to culture in vitro.
Single-Cell Genome Sequencing Market, Dynamics:
Advancements in single-cell sequencing have improved the detection method and analysis of infectious diseases, food-borne pathogens, and microbial diversities. Development in the field of single-cell genome sequencing offers a window into the extent and nature of transcriptomic heterogeneity and genomic, which are expected to propel the growth of the single-cell genome sequencing market. The single-cell genomics allows for insight into the heterogeneity of tissues and organs in normal development and function. It also enables the study of disease processes in specific cell types. The one of the latest trends in single-cell genomics market has witnessed a combination of multiple molecular readouts from thousands of single cells. The application of single-cell combinatorial indexing has permitted for simultaneous analysis of the open chromatin and RNA profiles of individual cells. On the other hand, high cost, and analytical challenges in measurement of the single molecule of DNA are expected to limit the growth of the global single-cell genome sequencing market.Single-Cell Genome Sequencing Market, Segment Analysis:
The cancer is one of leading non-communicable disease. According to World Health Organization, it is the second leading cause of death. According to a report by International Age for Research on Cancer in 2021, more than 18 million new cases of cancer were registered with around 9 million death and more than 35 million people are living with cancer worldwide. The cancer segment is expected to grow at xx% rate of CAGR during the forecast period. An Introduction of new therapies for the treatment of cancer like personalized medicine (Immuno-oncology and others) is expected to increase the adaption of single cell genomic sequencing for evolving research to observe cellular level changes in cancer cells. NGS platform is expected to contribute xx% share in the global single-cell genome sequencing market. With an introduction of next-generation sequencing, high-throughput measurements of biomolecules in tissues especially RNA and DNA have developed rapidly across the globe. The NGS platform permits parallel sequencing of multiple targeted genomic regions in many samples to detect concomitant mutations. It can deal with maximal tumor genomic assessment. The development of next-generation sequencing (NGS) technologies has provided many valuable insights into complex biological systems, which are ranging from cancer genomics to diverse microbial communities. The adoption of NGS-based technologies for genomics, transcriptomics, and epigenomics are now increasingly focused on the characterization of individual cells, which allow researchers to uncover new and potentially unexpected biological discoveries.Single-Cell Genome Sequencing Market, Regional Insights:
North America is expected to contribute xx% share in global single-cell genome sequencing market during the forecast period. The growth in the market is attributed to the rise in single cell research funding along with continuous establishment of Single Cell Genome sequencing (SCG) centers and presence of many key players across the region. High adoption of advancing Tools and Technologies are expected to boost the market growth. In addition, increasing investigations in genomics are expected to drive the growth of the market. For instance, Researchers at the University of California has conducted the study of microfluidic droplet barcoding at ultra-high-throughput analyzed distributions of phage sequences, antibiotic resistance genes, and virulence factors. Currently, single-cell genome sequencing market key players are forming partnerships with other key players to enhance their product portfolios. Key Players are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge across the globe. For instance, in 2018, Illumina has launched semiconductor-based sequencing system iSeq 100t, which uses sequencing-by-synthesis chemistry with CMOS detection technology. Single-Cell Genome Sequencing Market, Competitive Analysis: Technological advancements in the field of single-cell genome sequencing are playing an instrumental role in the development of the single-cell genome sequencing market. Many market key players are focusing on the collaboration to expand their global footprint. For instance, Bio-Rad Laboratories, Inc. and Illumina, Inc has collaborated to develop an innovative workflow for single-cell genome sequencing analysis. The technologically innovative platforms offer intuitive analysis software solutions. Growing focus of Key players on product development are triggering market growth. Moreover, supportive government policies are expected to boost the market growth during the forecast period. The objective of the report is to present a comprehensive analysis of the Global Single-Cell Genome Sequencing Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Single-Cell Genome Sequencing Market dynamics, structure by analyzing the market segments and projects the Global Single-Cell Genome Sequencing Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Single-Cell Genome Sequencing Market make the report investor’s guide.Single-Cell Genome Sequencing Market Scope: Inquire before buying
Global Single-Cell Genome Sequencing Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 1.79 Bn. Forecast Period 2023 to 2029 CAGR: 14.32% Market Size in 2029: US $ 4.57 Bn. Segments Covered: by Product • Instruments • Reagents by Technology • NGS • PCR • qPCR • Microarray • MDA by Workflow • Single-cell isolation • Sample preparation • Genomic analysis by End-User •Academic & research laboratories • Biotechnology & biopharmaceutical companies • Clinics • Others by Disease Area • Cancer • Immunology • Prenatal diagnosis • Neurobiology • Microbiology • Others Single-Cell Genome Sequencing Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Single-Cell Genome Sequencing Market Key Players are:
• Fludigim • QIAGEN • Illumina • F Hoffmann-La Roche Ltd. • ThermoFisher Scientific, Inc. • Bio-Rad • 10X Genomics, Inc. • BD • Oxford Nanopore Technologies • BGI • Pacific Biosciences Inc. • DNA Electronics Ltd. • Agilent Technologies Inc • NuGEN Technologies, Inc. • Novogene Co. Ltd. • Takara Bio, Inc. Frequently Asked Questions: 1. Which region has the largest share in Global Single-Cell Genome Sequencing Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Single-Cell Genome Sequencing Market? Ans: The Global Single-Cell Genome Sequencing Market is growing at a CAGR of 14.32% during forecasting period 2023-2029. 3. What is scope of the Global Single-Cell Genome Sequencing market report? Ans: Global Single-Cell Genome Sequencing Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Single-Cell Genome Sequencing market? Ans: The important key players in the Global Single-Cell Genome Sequencing Market are – Fludigim, QIAGEN, Illumina, F Hoffmann-La Roche Ltd., ThermoFisher Scientific, Inc., Bio-Rad, 10X Genomics, Inc., BD, Oxford Nanopore Technologies, BGI, Pacific Biosciences Inc., DNA Electronics Ltd., Agilent Technologies Inc, NuGEN Technologies, Inc., Novogene Co. Ltd., Takara Bio, and Inc. 5. What is the study period of this market? Ans: The Global Single-Cell Genome Sequencing Market is studied from 2022 to 2029.
Global Single-Cell Genome Sequencing Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Single-Cell Genome Sequencing Market Size, by Market Value (US$ Bn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Single-Cell Genome Sequencing Market Analysis and Forecast 6.1. Single-Cell Genome Sequencing Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Single-Cell Genome Sequencing Market Analysis and Forecast, By End User 7.1. Introduction and Definition 7.2. Key Findings 7.3. Single-Cell Genome Sequencing Market Value Share Analysis, By End User 7.4. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, By End User 7.5. Single-Cell Genome Sequencing Market Analysis, By End User 7.6. Single-Cell Genome Sequencing Market Attractiveness Analysis, By End User 8. Global Single-Cell Genome Sequencing Market Analysis and Forecast, By Product Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 8.4. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, By Product Type 8.5. Single-Cell Genome Sequencing Market Analysis, By Product Type 8.6. Single-Cell Genome Sequencing Market Attractiveness Analysis, By Product Type 9. Global Single-Cell Genome Sequencing Market Analysis and Forecast, By Technology 9.1. Introduction and Definition 9.2. Key Findings 9.3. Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 9.4. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, By Technology 9.5. Single-Cell Genome Sequencing Market Analysis, By Technology 9.6. Single-Cell Genome Sequencing Market Attractiveness Analysis, By Technology 10. Global Single-Cell Genome Sequencing Market Analysis and Forecast, By Workflow 10.1. Introduction and Definition 10.2. Key Findings 10.3. Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 10.4. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, By Workflow 10.5. Single-Cell Genome Sequencing Market Analysis, By Workflow 10.6. Single-Cell Genome Sequencing Market Attractiveness Analysis, By Workflow 11. Global Single-Cell Genome Sequencing Market Analysis and Forecast, By Disease Area 11.1. Introduction and Definition 11.2. Key Findings 11.3. Single-Cell Genome Sequencing Market Value Share Analysis, By Disease Area 11.4. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, By Disease Area 11.5. Single-Cell Genome Sequencing Market Analysis, By Disease Area 11.6. Single-Cell Genome Sequencing Market Attractiveness Analysis, By Disease Area 12. Global Single-Cell Genome Sequencing Market Analysis, by Region 12.1. Single-Cell Genome Sequencing Market Value Share Analysis, by Region 12.2. Single-Cell Genome Sequencing Market Size (US$ Bn) Forecast, by Region 12.3. Single-Cell Genome Sequencing Market Attractiveness Analysis, by Region 13. North America Single-Cell Genome Sequencing Market Analysis 13.1. Key Findings 13.2. North America Single-Cell Genome Sequencing Market Overview 13.3. North America Single-Cell Genome Sequencing Market Value Share Analysis, By End User 13.4. North America Single-Cell Genome Sequencing Market Forecast, By End User 13.4.1. Academic & research laboratories 13.4.2. Biotechnology & biopharmaceutical companies 13.4.3. Clinics 13.4.4. Others 13.5. North America Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 13.6. North America Single-Cell Genome Sequencing Market Forecast, By Product Type 13.6.1. Instruments 13.6.2. Reagents 13.7. North America Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 13.8. North America Single-Cell Genome Sequencing Market Forecast, By Technology 13.8.1. NGS 13.8.2. PCR 13.8.3. qPCR 13.8.4. Microarray 13.8.5. MDA 13.9. North America Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 13.10. North America Single-Cell Genome Sequencing Market Forecast, By Workflow 13.10.1. Single-cell isolation 13.10.2. Sample preparation 13.10.3. Others 13.11. North America Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 13.12. North America Single-Cell Genome Sequencing Market Forecast, By Disease Area 13.12.1. Cancer 13.12.2. Immunology 13.12.3. Prenatal diagnosis 13.12.4. Neurobiology 13.12.5. Microbiology 13.12.6. Others 13.13. North America Single-Cell Genome Sequencing Market Value Share Analysis, by Country 13.14. North America Single-Cell Genome Sequencing Market Forecast, by Country 13.15. North America Single-Cell Genome Sequencing Market Analysis, by Country 13.15.1. U.S. 13.15.2. Canada 13.16. U.S. Single-Cell Genome Sequencing Market Forecast, By End User 13.16.1. Academic & research laboratories 13.16.2. Biotechnology & biopharmaceutical companies 13.16.3. Clinics 13.16.4. Others 13.17. U.S. Single-Cell Genome Sequencing Market Forecast, By Product Type 13.17.1. Instruments 13.17.2. Reagents 13.18. U.S. Single-Cell Genome Sequencing Market Forecast, By Technology 13.18.1. NGS 13.18.2. PCR 13.18.3. qPCR 13.18.4. Microarray 13.18.5. MDA 13.19. U.S. Single-Cell Genome Sequencing Market Forecast, By Workflow 13.19.1. Single-cell isolation 13.19.2. Sample preparation 13.19.3. Others 13.20. U.S. Single-Cell Genome Sequencing Market Forecast, By Disease Area 13.20.1. Cancer 13.20.2. Immunology 13.20.3. Prenatal diagnosis 13.20.4. Neurobiology 13.20.5. Microbiology 13.20.6. Others 13.21. Canada Single-Cell Genome Sequencing Market Forecast, By End User 13.21.1. Academic & research laboratories 13.21.2. Biotechnology & biopharmaceutical companies 13.21.3. Clinics 13.21.4. Others 13.22. Canada Single-Cell Genome Sequencing Market Forecast, By Product Type 13.22.1. Instruments 13.22.2. Reagents 13.23. Canada Single-Cell Genome Sequencing Market Forecast, By Technology 13.23.1. NGS 13.23.2. PCR 13.23.3. qPCR 13.23.4. Microarray 13.23.5. MDA 13.24. Canada Single-Cell Genome Sequencing Market Forecast, By Workflow 13.24.1. Single-cell isolation 13.24.2. Sample preparation 13.24.3. Others 13.25. Canada Single-Cell Genome Sequencing Market Forecast, By Disease Area 13.25.1. Cancer 13.25.2. Immunology 13.25.3. Prenatal diagnosis 13.25.4. Neurobiology 13.25.5. Microbiology 13.25.6. Others 13.26. North America Single-Cell Genome Sequencing Market Attractiveness Analysis 13.26.1. By End User 13.26.2. By Product Type 13.26.3. By Technology 13.26.4. By Workflow 13.27. PEST Analysis 13.28. Key Trends 13.29. Key Developments 14. Europe Single-Cell Genome Sequencing Market Analysis 14.1. Key Findings 14.2. Europe Single-Cell Genome Sequencing Market Overview 14.3. Europe Single-Cell Genome Sequencing Market Value Share Analysis, By End User 14.4. Europe Single-Cell Genome Sequencing Market Forecast, By End User 14.4.1. Academic & research laboratories 14.4.2. Biotechnology & biopharmaceutical companies 14.4.3. Clinics 14.4.4. Others 14.5. Europe Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 14.6. Europe Single-Cell Genome Sequencing Market Forecast, By Product Type 14.6.1. Instruments 14.6.2. Reagents 14.7. Europe Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 14.8. Europe Single-Cell Genome Sequencing Market Forecast, By Technology 14.8.1. NGS 14.8.2. PCR 14.8.3. qPCR 14.8.4. Microarray 14.8.5. MDA 14.9. Europe Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 14.10. Europe Single-Cell Genome Sequencing Market Forecast, By Workflow 14.10.1. Single-cell isolation 14.10.2. Sample preparation 14.10.3. Others 14.11. Europe Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.11.1. Cancer 14.11.2. Immunology 14.11.3. Prenatal diagnosis 14.11.4. Neurobiology 14.11.5. Microbiology 14.11.6. Others 14.12. Europe Single-Cell Genome Sequencing Market Value Share Analysis, by Country 14.13. Europe Single-Cell Genome Sequencing Market Forecast, by Country 14.13.1. Germany 14.13.2. U.K. 14.13.3. France 14.13.4. Italy 14.13.5. Spain 14.13.6. Norway 14.13.7. Russia 14.13.8. Rest of Europe 14.14. Europe Single-Cell Genome Sequencing Market Analysis, by Country 14.15. Germany Single-Cell Genome Sequencing Market Forecast, By End User 14.15.1. Academic & research laboratories 14.15.2. Biotechnology & biopharmaceutical companies 14.15.3. Clinics 14.15.4. Others 14.16. Germany Single-Cell Genome Sequencing Market Forecast, By Product Type 14.16.1. Instruments 14.16.2. Reagents 14.17. Germany Single-Cell Genome Sequencing Market Forecast, By Technology 14.17.1. NGS 14.17.2. PCR 14.17.3. qPCR 14.17.4. Microarray 14.17.5. MDA 14.18. Germany Single-Cell Genome Sequencing Market Forecast, By Workflow 14.18.1. Single-cell isolation 14.18.2. Sample preparation 14.18.3. Others 14.19. Germany Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.19.1. Cancer 14.19.2. Immunology 14.19.3. Prenatal diagnosis 14.19.4. Neurobiology 14.19.5. Microbiology 14.19.6. Others 14.20. U.K. Single-Cell Genome Sequencing Market Forecast, By End User 14.20.1. Academic & research laboratories 14.20.2. Biotechnology & biopharmaceutical companies 14.20.3. Clinics 14.20.4. Others 14.21. U.K. Single-Cell Genome Sequencing Market Forecast, By Product Type 14.21.1. Instruments 14.21.2. Reagents 14.22. U.K. Single-Cell Genome Sequencing Market Forecast, By Technology 14.22.1. NGS 14.22.2. PCR 14.22.3. qPCR 14.22.4. Microarray 14.22.5. MDA 14.23. U.K. Single-Cell Genome Sequencing Market Forecast, By Workflow 14.23.1. Single-cell isolation 14.23.2. Sample preparation 14.23.3. Others 14.24. U.K Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.24.1. Cancer 14.24.2. Immunology 14.24.3. Prenatal diagnosis 14.24.4. Neurobiology 14.24.5. Microbiology 14.24.6. Others 14.25. France Single-Cell Genome Sequencing Market Forecast, By End User 14.25.1. Academic & research laboratories 14.25.2. Biotechnology & biopharmaceutical companies 14.25.3. Clinics 14.25.4. Others 14.26. France Single-Cell Genome Sequencing Market Forecast, By Product Type 14.26.1. Instruments 14.26.2. Reagents 14.27. France Single-Cell Genome Sequencing Market Forecast, By Technology 14.27.1. NGS 14.27.2. PCR 14.27.3. qPCR 14.27.4. Microarray 14.27.5. MDA 14.28. France Single-Cell Genome Sequencing Market Forecast, By Workflow 14.28.1. Single-cell isolation 14.28.2. Sample preparation 14.28.3. Others 14.29. France Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.29.1. Cancer 14.29.2. Immunology 14.29.3. Prenatal diagnosis 14.29.4. Neurobiology 14.29.5. Microbiology 14.29.6. Others 14.30. Italy Single-Cell Genome Sequencing Market Forecast, By End User 14.30.1. Academic & research laboratories 14.30.2. Biotechnology & biopharmaceutical companies 14.30.3. Clinics 14.30.4. Others 14.31. Italy Single-Cell Genome Sequencing Market Forecast, By Product Type 14.31.1. Instruments 14.31.2. Reagents 14.32. Italy Single-Cell Genome Sequencing Market Forecast, By Technology 14.32.1. NGS 14.32.2. PCR 14.32.3. qPCR 14.32.4. Microarray 14.32.5. MDA 14.33. Italy Single-Cell Genome Sequencing Market Forecast, By Workflow 14.33.1. Single-cell isolation 14.33.2. Sample preparation 14.33.3. Others 14.34. Italy Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.34.1. Cancer 14.34.2. Immunology 14.34.3. Prenatal diagnosis 14.34.4. Neurobiology 14.34.5. Microbiology 14.34.6. Others 14.35. Spain Single-Cell Genome Sequencing Market Forecast, By End User 14.35.1. Academic & research laboratories 14.35.2. Biotechnology & biopharmaceutical companies 14.35.3. Clinics 14.35.4. Others 14.36. Spain Single-Cell Genome Sequencing Market Forecast, By Product Type 14.36.1. Instruments 14.36.2. Reagents 14.37. Spain Single-Cell Genome Sequencing Market Forecast, By Technology 14.37.1. NGS 14.37.2. PCR 14.37.3. qPCR 14.37.4. Microarray 14.37.5. MDA 14.38. Spain Single-Cell Genome Sequencing Market Forecast, By Workflow 14.38.1. Single-cell isolation 14.38.2. Sample preparation 14.38.3. Others 14.39. Spain Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.39.1. Cancer 14.39.2. Immunology 14.39.3. Prenatal diagnosis 14.39.4. Neurobiology 14.39.5. Microbiology 14.39.6. Others 14.40. Norway Single-Cell Genome Sequencing Market Forecast, By End User 14.40.1. Academic & research laboratories 14.40.2. Biotechnology & biopharmaceutical companies 14.40.3. Clinics 14.40.4. Others 14.41. Norway Single-Cell Genome Sequencing Market Forecast, By Product Type 14.41.1. Instruments 14.41.2. Reagents 14.42. Norway Single-Cell Genome Sequencing Market Forecast, By Technology 14.42.1. NGS 14.42.2. PCR 14.42.3. qPCR 14.42.4. Microarray 14.42.5. MDA 14.43. Norway Single-Cell Genome Sequencing Market Forecast, By Workflow 14.43.1. Single-cell isolation 14.43.2. Sample preparation 14.43.3. Others 14.44. Norway Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.44.1. Cancer 14.44.2. Immunology 14.44.3. Prenatal diagnosis 14.44.4. Neurobiology 14.44.5. Microbiology 14.44.6. Others 14.45. Russia Single-Cell Genome Sequencing Market Forecast, By End User 14.45.1. Academic & research laboratories 14.45.2. Biotechnology & biopharmaceutical companies 14.45.3. Clinics 14.45.4. Others 14.46. Russia Single-Cell Genome Sequencing Market Forecast, By Product Type 14.46.1. Instruments 14.46.2. Reagents 14.47. Russia Single-Cell Genome Sequencing Market Forecast, By Technology 14.47.1. NGS 14.47.2. PCR 14.47.3. qPCR 14.47.4. Microarray 14.47.5. MDA 14.48. Russia Single-Cell Genome Sequencing Market Forecast, By Workflow 14.48.1. Single-cell isolation 14.48.2. Sample preparation 14.48.3. Others 14.49. Russia Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.49.1. Cancer 14.49.2. Immunology 14.49.3. Prenatal diagnosis 14.49.4. Neurobiology 14.49.5. Microbiology 14.49.6. Others 14.50. Rest of Europe Single-Cell Genome Sequencing Market Forecast, By End User 14.50.1. Academic & research laboratories 14.50.2. Biotechnology & biopharmaceutical companies 14.50.3. Clinics 14.50.4. Others 14.51. Rest of Europe Single-Cell Genome Sequencing Market Forecast, By Product Type 14.51.1. Instruments 14.51.2. Reagents 14.52. Rest of Europe Single-Cell Genome Sequencing Market Forecast, By Technology 14.52.1. NGS 14.52.2. PCR 14.52.3. qPCR 14.52.4. Microarray 14.52.5. MDA 14.53. Rest Of Europe Single-Cell Genome Sequencing Market Forecast, By Workflow 14.53.1. Single-cell isolation 14.53.2. Sample preparation 14.53.3. Others 14.54. Rest Of Europe Single-Cell Genome Sequencing Market Forecast, By Disease Area 14.54.1. Cancer 14.54.2. Immunology 14.54.3. Prenatal diagnosis 14.54.4. Neurobiology 14.54.5. Microbiology 14.54.6. Others 14.55. Europe Single-Cell Genome Sequencing Market Attractiveness Analysis 14.55.1. By End User 14.55.2. By Product Type 14.55.3. By Technology 14.55.4. By Workflow 14.56. PEST Analysis 14.57. Key Trends 14.58. Key Developments 15. Asia Pacific Single-Cell Genome Sequencing Market Analysis 15.1. Key Findings 15.2. Asia Pacific Single-Cell Genome Sequencing Market Overview 15.3. Asia Pacific Single-Cell Genome Sequencing Market Value Share Analysis, By End User 15.4. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By End User 15.4.1. Academic & research laboratories 15.4.2. Biotechnology & biopharmaceutical companies 15.4.3. Clinics 15.4.4. Others 15.5. Asia Pacific Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 15.6. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Product Type 15.6.1. Instruments 15.6.2. Reagents 15.7. Asia Pacific Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 15.8. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Technology 15.8.1. NGS 15.8.2. PCR 15.8.3. qPCR 15.8.4. Microarray 15.8.5. MDA 15.9. Asia Pacific Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 15.10. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Workflow 15.10.1. Single-cell isolation 15.10.2. Sample preparation 15.10.3. Others 15.11. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.11.1. Cancer 15.11.2. Immunology 15.11.3. Prenatal diagnosis 15.11.4. Neurobiology 15.11.5. Microbiology 15.11.6. Others 15.12. Asia Pacific Single-Cell Genome Sequencing Market Value Share Analysis, by Country 15.13. Asia Pacific Single-Cell Genome Sequencing Market Forecast, by Country 15.13.1. China 15.13.2. India 15.13.3. Japan 15.13.4. South Korea 15.13.5. Australia 15.13.6. Malaysia 15.13.7. Indonesia 15.13.8. Rest of Asia Pacific 15.14. Asia Pacific Single-Cell Genome Sequencing Market Analysis, by Country 15.15. China Single-Cell Genome Sequencing Market Forecast, By End User 15.15.1. Academic & research laboratories 15.15.2. Biotechnology & biopharmaceutical companies 15.15.3. Clinics 15.15.4. Others 15.16. China Single-Cell Genome Sequencing Market Forecast, By Product Type 15.16.1. Instruments 15.16.2. Reagents 15.17. China Single-Cell Genome Sequencing Market Forecast, By Technology 15.17.1. NGS 15.17.2. PCR 15.17.3. qPCR 15.17.4. Microarray 15.17.5. MDA 15.18. China Single-Cell Genome Sequencing Market Forecast, By Workflow 15.18.1. Single-cell isolation 15.18.2. Sample preparation 15.18.3. Others 15.19. China Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.19.1. Cancer 15.19.2. Immunology 15.19.3. Prenatal diagnosis 15.19.4. Neurobiology 15.19.5. Microbiology 15.19.6. Others 15.20. India Single-Cell Genome Sequencing Market Forecast, By End User 15.20.1. Academic & research laboratories 15.20.2. Biotechnology & biopharmaceutical companies 15.20.3. Clinics 15.20.4. Others 15.21. India Single-Cell Genome Sequencing Market Forecast, By Product Type 15.21.1. Instruments 15.21.2. Reagents 15.22. India Single-Cell Genome Sequencing Market Forecast, By Technology 15.22.1. NGS 15.22.2. PCR 15.22.3. qPCR 15.22.4. Microarray 15.22.5. MDA 15.23. India Single-Cell Genome Sequencing Market Forecast, By Workflow 15.23.1. Single-cell isolation 15.23.2. Sample preparation 15.23.3. Others 15.24. India Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.24.1. Cancer 15.24.2. Immunology 15.24.3. Prenatal diagnosis 15.24.4. Neurobiology 15.24.5. Microbiology 15.24.6. Others 15.25. Japan Single-Cell Genome Sequencing Market Forecast, By End User 15.25.1. Academic & research laboratories 15.25.2. Biotechnology & biopharmaceutical companies 15.25.3. Clinics 15.25.4. Others 15.26. Japan Single-Cell Genome Sequencing Market Forecast, By Product Type 15.26.1. Instruments 15.26.2. Reagents 15.27. Japan Single-Cell Genome Sequencing Market Forecast, By Technology 15.27.1. NGS 15.27.2. PCR 15.27.3. qPCR 15.27.4. Microarray 15.27.5. MDA 15.28. Japan Single-Cell Genome Sequencing Market Forecast, By Workflow 15.28.1. Single-cell isolation 15.28.2. Sample preparation 15.28.3. Others 15.29. Japan Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.29.1. Cancer 15.29.2. Immunology 15.29.3. Prenatal diagnosis 15.29.4. Neurobiology 15.29.5. Microbiology 15.29.6. Others 15.30. South Korea Single-Cell Genome Sequencing Market Forecast, By End User 15.30.1. Academic & research laboratories 15.30.2. Biotechnology & biopharmaceutical companies 15.30.3. Clinics 15.30.4. Others 15.31. South Korea Single-Cell Genome Sequencing Market Forecast, By Product Type 15.31.1. Instruments 15.31.2. Reagents 15.32. South Korea Single-Cell Genome Sequencing Market Forecast, By Technology 15.32.1. NGS 15.32.2. PCR 15.32.3. qPCR 15.32.4. Microarray 15.32.5. MDA 15.33. South Korea Single-Cell Genome Sequencing Market Forecast, By Workflow 15.33.1. Single-cell isolation 15.33.2. Sample preparation 15.33.3. Others 15.34. South Korea Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.34.1. Cancer 15.34.2. Immunology 15.34.3. Prenatal diagnosis 15.34.4. Neurobiology 15.34.5. Microbiology 15.34.6. Others 15.35. Australia Single-Cell Genome Sequencing Market Forecast, By End User 15.35.1. Academic & research laboratories 15.35.2. Biotechnology & biopharmaceutical companies 15.35.3. Clinics 15.35.4. Others 15.36. Australia Single-Cell Genome Sequencing Market Forecast, By Product Type 15.36.1. Instruments 15.36.2. Reagents 15.37. Australia Single-Cell Genome Sequencing Market Forecast, By Technology 15.37.1. NGS 15.37.2. PCR 15.37.3. qPCR 15.37.4. Microarray 15.37.5. MDA 15.38. Australia Single-Cell Genome Sequencing Market Forecast, By Workflow 15.38.1. Single-cell isolation 15.38.2. Sample preparation 15.38.3. Others 15.39. Australia Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.39.1. Cancer 15.39.2. Immunology 15.39.3. Prenatal diagnosis 15.39.4. Neurobiology 15.39.5. Microbiology 15.39.6. Others 15.40. Malaysia Single-Cell Genome Sequencing Market Forecast, By End User 15.40.1. Academic & research laboratories 15.40.2. Biotechnology & biopharmaceutical companies 15.40.3. Clinics 15.40.4. Others 15.41. Malaysia Single-Cell Genome Sequencing Market Forecast, By Product Type 15.41.1. Instruments 15.41.2. Reagents 15.42. Malaysia Single-Cell Genome Sequencing Market Forecast, By Technology 15.42.1. NGS 15.42.2. PCR 15.42.3. qPCR 15.42.4. Microarray 15.42.5. MDA 15.43. Malaysia Single-Cell Genome Sequencing Market Forecast, By Workflow 15.43.1. Single-cell isolation 15.43.2. Sample preparation 15.43.3. Others 15.44. Malaysia Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.44.1. Cancer 15.44.2. Immunology 15.44.3. Prenatal diagnosis 15.44.4. Neurobiology 15.44.5. Microbiology 15.44.6. Others 15.45. Indonesia Single-Cell Genome Sequencing Market Forecast, By End User 15.45.1. Academic & research laboratories 15.45.2. Biotechnology & biopharmaceutical companies 15.45.3. Clinics 15.45.4. Others 15.46. Indonesia Single-Cell Genome Sequencing Market Forecast, By Product Type 15.46.1. Instruments 15.46.2. Reagents 15.47. Indonesia Single-Cell Genome Sequencing Market Forecast, By Technology 15.47.1. NGS 15.47.2. PCR 15.47.3. qPCR 15.47.4. Microarray 15.47.5. MDA 15.48. Indonesia Single-Cell Genome Sequencing Market Forecast, By Workflow 15.48.1. Single-cell isolation 15.48.2. Sample preparation 15.48.3. Others 15.49. Indonesia Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.49.1. Cancer 15.49.2. Immunology 15.49.3. Prenatal diagnosis 15.49.4. Neurobiology 15.49.5. Microbiology 15.49.6. Others 15.50. Rest of Asia Pacific Single-Cell Genome Sequencing Market Forecast, By End User 15.50.1. Academic & research laboratories 15.50.2. Biotechnology & biopharmaceutical companies 15.50.3. Clinics 15.50.4. Others 15.51. Rest of Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Product Type 15.51.1. Instruments 15.51.2. Reagents 15.52. Rest of Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Technology 15.52.1. NGS 15.52.2. PCR 15.52.3. qPCR 15.52.4. Microarray 15.52.5. MDA 15.53. Rest of Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Workflow 15.53.1. Single-cell isolation 15.53.2. Sample preparation 15.53.3. Others 15.54. Asia Pacific Single-Cell Genome Sequencing Market Attractiveness Analysis 15.54.1. By End User 15.54.2. By Product Type 15.54.3. By Technology 15.54.4. By Workflow 15.55. Asia Pacific Single-Cell Genome Sequencing Market Forecast, By Disease Area 15.55.1. Cancer 15.55.2. Immunology 15.55.3. Prenatal diagnosis 15.55.4. Neurobiology 15.55.5. Microbiology 15.55.6. Others 15.56. PEST Analysis 15.57. Key Trends 15.58. Key Developments 16. Middle East & Africa Single-Cell Genome Sequencing Market Analysis 16.1. Key Findings 16.2. Middle East & Africa Single-Cell Genome Sequencing Market Overview 16.3. Middle East & Africa Single-Cell Genome Sequencing Market Value Share Analysis, By End User 16.4. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By End User 16.4.1. Academic & research laboratories 16.4.2. Biotechnology & biopharmaceutical companies 16.4.3. Clinics 16.4.4. Others 16.5. Middle East & Africa Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 16.6. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Product Type 16.6.1. Instruments 16.6.2. Reagents 16.7. Middle East & Africa Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 16.8. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Technology 16.8.1. NGS 16.8.2. PCR 16.8.3. qPCR 16.8.4. Microarray 16.8.5. MDA 16.9. Middle East & Africa Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 16.10. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Workflow 16.10.1. Single-cell isolation 16.10.2. Sample preparation 16.10.3. Others 16.11. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Disease Area 16.11.1. Cancer 16.11.2. Immunology 16.11.3. Prenatal diagnosis 16.11.4. Neurobiology 16.11.5. Microbiology 16.11.6. Others 16.12. Middle East & Africa Single-Cell Genome Sequencing Market Value Share Analysis, by Country 16.13. Middle East & Africa Single-Cell Genome Sequencing Market Forecast, by Country 16.13.1. GCC 16.13.2. South Africa 16.13.3. Rest of Middle East & Africa 16.14. Middle East & Africa Single-Cell Genome Sequencing Market Analysis, by Country 16.15. GCC Single-Cell Genome Sequencing Market Forecast, By End User 16.15.1. Academic & research laboratories 16.15.2. Biotechnology & biopharmaceutical companies 16.15.3. Clinics 16.15.4. Others 16.16. GCC Single-Cell Genome Sequencing Market Forecast, By Product Type 16.16.1. Instruments 16.16.2. Reagents 16.17. GCC Single-Cell Genome Sequencing Market Forecast, By Technology 16.17.1. NGS 16.17.2. PCR 16.17.3. qPCR 16.17.4. Microarray 16.17.5. MDA 16.18. GCC Single-Cell Genome Sequencing Market Forecast, By Workflow 16.18.1. Single-cell isolation 16.18.2. Sample preparation 16.18.3. Others 16.19. GCC Single-Cell Genome Sequencing Market Forecast, By Disease Area 16.19.1. Cancer 16.19.2. Immunology 16.19.3. Prenatal diagnosis 16.19.4. Neurobiology 16.19.5. Microbiology 16.19.6. Others 16.20. South Africa Single-Cell Genome Sequencing Market Forecast, By End User 16.20.1. Academic & research laboratories 16.20.2. Biotechnology & biopharmaceutical companies 16.20.3. Clinics 16.20.4. Others 16.21. South Africa Single-Cell Genome Sequencing Market Forecast, By Product Type 16.21.1. Instruments 16.21.2. Reagents 16.22. South Africa Single-Cell Genome Sequencing Market Forecast, By Technology 16.22.1. NGS 16.22.2. PCR 16.22.3. qPCR 16.22.4. Microarray 16.22.5. MDA 16.23. South Africa Single-Cell Genome Sequencing Market Forecast, By Workflow 16.23.1. Single-cell isolation 16.23.2. Sample preparation 16.23.3. Others 16.24. South Africa Single-Cell Genome Sequencing Market Forecast, By Disease Area 16.24.1. Cancer 16.24.2. Immunology 16.24.3. Prenatal diagnosis 16.24.4. Neurobiology 16.24.5. Microbiology 16.24.6. Others 16.25. Rest of Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By End User 16.25.1. Academic & research laboratories 16.25.2. Biotechnology & biopharmaceutical companies 16.25.3. Clinics 16.25.4. Others 16.26. Rest of Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Product Type 16.26.1. Instruments 16.26.2. Reagents 16.27. Rest of Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Technology 16.27.1. NGS 16.27.2. PCR 16.27.3. qPCR 16.27.4. Microarray 16.27.5. MDA 16.28. Rest of Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Workflow 16.28.1. Single-cell isolation 16.28.2. Sample preparation 16.28.3. Others 16.29. Rest of Middle East & Africa Single-Cell Genome Sequencing Market Forecast, By Disease Area 16.29.1. Cancer 16.29.2. Immunology 16.29.3. Prenatal diagnosis 16.29.4. Neurobiology 16.29.5. Microbiology 16.29.6. Others 16.30. Middle East & Africa Single-Cell Genome Sequencing Market Attractiveness Analysis 16.30.1. By End User 16.30.2. By Product Type 16.30.3. By Technology 16.30.4. By Workflow 16.31. PEST Analysis 16.32. Key Trends 16.33. Key Developments 17. South America Single-Cell Genome Sequencing Market Analysis 17.1. Key Findings 17.2. South America Single-Cell Genome Sequencing Market Overview 17.3. South America Single-Cell Genome Sequencing Market Value Share Analysis, By End User 17.4. South America Single-Cell Genome Sequencing Market Forecast, By End User 17.4.1. Academic & research laboratories 17.4.2. Biotechnology & biopharmaceutical companies 17.4.3. Clinics 17.4.4. Others 17.5. South America Single-Cell Genome Sequencing Market Value Share Analysis, By Product Type 17.6. South America Single-Cell Genome Sequencing Market Forecast, By Product Type 17.6.1. Instruments 17.6.2. Reagents 17.7. South America Single-Cell Genome Sequencing Market Value Share Analysis, By Technology 17.8. South America Single-Cell Genome Sequencing Market Forecast, By Technology 17.8.1. NGS 17.8.2. PCR 17.8.3. qPCR 17.8.4. Microarray 17.8.5. MDA 17.9. South America Single-Cell Genome Sequencing Market Value Share Analysis, By Workflow 17.10. South America Single-Cell Genome Sequencing Market Forecast, By Workflow 17.10.1. Single-cell isolation 17.10.2. Sample preparation 17.10.3. Others 17.11. South America Single-Cell Genome Sequencing Market Forecast, By Disease Area 17.11.1. Cancer 17.11.2. Immunology 17.11.3. Prenatal diagnosis 17.11.4. Neurobiology 17.11.5. Microbiology 17.11.6. Others 17.12. South America Single-Cell Genome Sequencing Market Value Share Analysis, by Country 17.13. South America Single-Cell Genome Sequencing Market Forecast, by Country 17.13.1. Brazil 17.13.2. Mexico 17.13.3. Argentina 17.13.4. Rest of South America 17.14. South America Single-Cell Genome Sequencing Market Analysis, by Country 17.15. Brazil Single-Cell Genome Sequencing Market Forecast, By End User 17.15.1. Academic & research laboratories 17.15.2. Biotechnology & biopharmaceutical companies 17.15.3. Clinics 17.15.4. Others 17.16. Brazil Single-Cell Genome Sequencing Market Forecast, By Product Type 17.16.1. Instruments 17.16.2. Reagents 17.17. Brazil Single-Cell Genome Sequencing Market Forecast, By Technology 17.17.1. NGS 17.17.2. PCR 17.17.3. qPCR 17.17.4. Microarray 17.17.5. MDA 17.18. Brazil Single-Cell Genome Sequencing Market Forecast, By Workflow 17.18.1. Single-cell isolation 17.18.2. Sample preparation 17.18.3. Others 17.19. Brazil Single-Cell Genome Sequencing Market Forecast, By Disease Area 17.19.1. Cancer 17.19.2. Immunology 17.19.3. Prenatal diagnosis 17.19.4. Neurobiology 17.19.5. Microbiology 17.19.6. Others 17.20. Mexico Single-Cell Genome Sequencing Market Forecast, By End User 17.20.1. Academic & research laboratories 17.20.2. Biotechnology & biopharmaceutical companies 17.20.3. Clinics 17.20.4. Others 17.21. Mexico Single-Cell Genome Sequencing Market Forecast, By Product Type 17.21.1. Instruments 17.21.2. Reagents 17.22. Mexico Single-Cell Genome Sequencing Market Forecast, By Technology 17.22.1. NGS 17.22.2. PCR 17.22.3. qPCR 17.22.4. Microarray 17.22.5. MDA 17.23. Mexico Single-Cell Genome Sequencing Market Forecast, By Workflow 17.23.1. Single-cell isolation 17.23.2. Sample preparation 17.23.3. Others 17.24. Mexico Single-Cell Genome Sequencing Market Forecast, By Disease Area 17.24.1. Cancer 17.24.2. Immunology 17.24.3. Prenatal diagnosis 17.24.4. Neurobiology 17.24.5. Microbiology 17.24.6. Others 17.25. Argentina Single-Cell Genome Sequencing Market Forecast, By End User 17.25.1. Academic & research laboratories 17.25.2. Biotechnology & biopharmaceutical companies 17.25.3. Clinics 17.25.4. Others 17.26. Argentina Single-Cell Genome Sequencing Market Forecast, By Product Type 17.26.1. Instruments 17.26.2. Reagents 17.27. Argentina Single-Cell Genome Sequencing Market Forecast, By Technology 17.27.1. NGS 17.27.2. PCR 17.27.3. qPCR 17.27.4. Microarray 17.27.5. MDA 17.28. Argentina Single-Cell Genome Sequencing Market Forecast, By Workflow 17.28.1. Single-cell isolation 17.28.2. Sample preparation 17.28.3. Others 17.29. Argentina Single-Cell Genome Sequencing Market Forecast, By Disease Area 17.29.1. Cancer 17.29.2. Immunology 17.29.3. Prenatal diagnosis 17.29.4. Neurobiology 17.29.5. Microbiology 17.29.6. Others 17.30. Rest of South America Single-Cell Genome Sequencing Market Forecast, By End User 17.30.1. Academic & research laboratories 17.30.2. Biotechnology & biopharmaceutical companies 17.30.3. Clinics 17.30.4. Others 17.31. Rest of South America Single-Cell Genome Sequencing Market Forecast, By Product Type 17.31.1. Instruments 17.31.2. Reagents 17.32. Rest of South America Single-Cell Genome Sequencing Market Forecast, By Technology 17.32.1. NGS 17.32.2. PCR 17.32.3. qPCR 17.32.4. Microarray 17.32.5. MDA 17.33. Rest of South America Single-Cell Genome Sequencing Market Forecast, By Workflow 17.33.1. Single-cell isolation 17.33.2. Sample preparation 17.33.3. Others 17.34. Rest of South America Single-Cell Genome Sequencing Market Forecast, By Disease Area 17.34.1. Cancer 17.34.2. Immunology 17.34.3. Prenatal diagnosis 17.34.4. Neurobiology 17.34.5. Microbiology 17.34.6. Others 17.35. South America Single-Cell Genome Sequencing Market Attractiveness Analysis 17.35.1. By End User 17.35.2. By Product Type 17.35.3. By Technology 17.35.4. By Workflow 17.35.5. By Disease Area 17.36. PEST Analysis 17.37. Key Trends 17.38. Key Developments 18. Company Profiles 18.1. Market Share Analysis, by Company 18.2. Competition Matrix 18.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 18.2.2. New Product Launches and Product Enhancements 18.2.3. Market Consolidation 18.2.3.1. M&A by Regions, Investment and Applications 18.2.3.2. M&A Key Players, Forward Integration and Backward Integration 18.3. Company Profiles: Key Players 18.3.1. Fludigim 18.3.1.1. Company Overview 18.3.1.2. Financial Overview 18.3.1.3. Product Portfolio 18.3.1.4. Business Strategy 18.3.1.5. Recent Developments 18.3.1.6. Development Footprint 18.3.2. QIAGEN 18.3.3. Illumina 18.3.4. F Hoffmann-La Roche Ltd. 18.3.5. ThermoFisher Scientific, Inc. 18.3.6. Bio-Rad 18.3.7. 10X Genomics, Inc. 18.3.8. BD 18.3.9. Oxford Nanopore Technologies 18.3.10. BGI 18.3.11. Pacific Biosciences Inc. 18.3.12. DNA Electronics Ltd. 18.3.13. Agilent Technologies Inc 18.3.14. NuGEN Technologies, Inc. 18.3.15. Novogene Co. Ltd. 18.3.16. Takara Bio, Inc. 19. Primary Key Insights